Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.

Li, Qian; Ganguly, Rahul; Ganz, Michael L; Gamble, Cory; Dang-Tan, Tam

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.

Li, Qian; Ganguly, Rahul; Ganz, Michael L; Gamble, Cory; Dang-Tan, Tam.

Afiliación

Li Q; Evidera, 500 Totten Pond Road, 5th Floor, Waltham, MA, 02451, USA. Qian.Li@Evidera.com.
Ganguly R; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.
Ganz ML; Evidera, 500 Totten Pond Road, 5th Floor, Waltham, MA, 02451, USA.
Gamble C; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.
Dang-Tan T; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.

Diabetes Ther ; 9(3): 1279-1293, 2018 Jun.

Article en En | MEDLINE | ID: mdl-29744818

Palabras clave

Clinical effectiveness; Costs; HbA1c; Liraglutide; Long-term; Sitagliptin; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Diabetes Ther Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google